Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan-Reference-Cited by-同舟云学术

Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan

Published:2022-05-18 Issue:6 Volume:6 Page:395-401
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Hagiwara Hideki¹^ORCID,Ito Yoshiki¹,Ohta Takashi¹^ORCID,Nozaki Yasutoshi¹,Iwamoto Takayuki¹,Hosui Atsushi²,Hiramatsu Naoki²,Tahata Yuki³^ORCID,Sakamori Ryotaro³^ORCID,Hikita Hayato³,Hayashi Norio¹

Affiliation:

1. Department of Gastroenterology and Hepatology Kansai Rosai Hospital Amagasaki Hyogo Japan

2. Department of Gastroenterology and Hepatology Osaka Rosai Hospital Sakai Osaka Japan

3. Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Osaka Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12745

Reference25 articles.

1. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan

2. Antiviral therapy for chronic hepatitis C: past, present, and future

3. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral

4. A nationwide cross-sectional survey on hepatitis B and C screening among workers in Japan

5. The Ministry of Health.Labour and Welfare of Japan. Annual health labour and welfare report 2020. (4). Working Cond/Lab Relat. Available from URL:https://www.mhlw.go.jp/english/wp/wp-hw13/dl/04e.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24